Clover Health is positioned for a major turnaround, with operations and profitability metrics improving sharply. See why CLOV stock is a Buy.
Clover Health Investments CLOV is well poised for growth in the coming quarters, courtesy of its broad product spectrum. This optimism is primarily driven by its technology-first care model, as ...
CMS signaled a net 0.09% year-over-year increase in MA funding, far below Wall Street expectations for 4%–6% growth, and outlined tighter risk-adjustment rules including limits on diagnoses captured ...
Shares of Clover Health (CLOV) plunged ~20% on Wednesday following the company’s Q3 2025 results, as the health insurer sharply lowered its full-year guidance for adjusted EBITDA despite increasing ...
Detailed price information for Clover Health Investments Corp (CLOV-Q) from The Globe and Mail including charting and trades.
Investors in Clover Health Investments Corp (Symbol: CLOV) saw new options become available today, for the December 26th expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...
Detailed price information for Clover Health Investments Corp (CLOV-Q) from The Globe and Mail including charting and trades.
Clover Health Investments CLOV is well poised for growth in the coming quarters, courtesy of its broad product spectrum. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results